10 Best ARK Stocks to Buy Right Now
In this article, we will take a look at the 10 Best ARK Stocks to Buy Right Now.
10X Genomics Inc. (TXG)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 10,003,057 | $383,517,223 | -15% | 2.49% |
| 2. | Quantinno Capital Hoon Kim | 5,469,698 | $209,708,221 | +2% | 0.25% |
| 3. | Citadel Investment Group Ken Griffin | 2,779,213 | $106,555,026 | +274% | 0.01% |
| 4. | AQR Capital Management Cliff Asness | 2,026,464 | $74,695,463 | -21% | 0.03% |
| 5. | Point72 Asset Management Steve Cohen | 1,852,776 | $71,035,432 | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.14 | 40,000 | $445,572.00 | 61,691 | 2025-02-21 | Filing | |
| $40.49 | 158 | $6,396.71 | 60,046 | 2022-05-13 | Filing | |
| $40.49 | 158 | $6,396.71 | 97,523 | 2022-05-13 | Filing | |
| $39.00 | 300,000 | $11,700,000.00 | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 300,000 | $11,700,000.00 | 300,000 | 2019-09-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.28 | 1,222 | $100,542.25 | 23,792 | 2026-09-22 | Filing | |
| $81.67 | 2,270 | $185,390.67 | 25,014 | 2026-09-22 | Filing | |
| $80.82 | 1,325 | $107,081.73 | 27,284 | 2026-09-22 | Filing | |
| $79.51 | 614 | $48,820.00 | 28,609 | 2026-09-22 | Filing | |
| $78.20 | 292 | $22,833.20 | 29,223 | 2026-09-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 131,768 | $9,747,713 | 0.01% | |
| 2. | 36,289 | $3,279,074 | 0.16% | |
| 3. | 33,979 | $3,070,342 | 0.36% | |
| 4. | 28,859 | $2,607,722 | 0.63% | |
| 5. | 18,185 | $1,643,197 | 0.14% |
News See All
3 AI ETFs With 70%+ Upside to Buy in September, According to Analysts
AI spending keeps rising across chips, cloud, and next‑gen software, and a few AI-focused ETFs still offer big upside. Three funds – Invesco NASDAQ...
Cathie Wood Buys the Dip with $41M in Broadcom, Cerebras, and Rocket Lab Shares; Sells $19M of Roblox
Cathie Wood’s ARK Invest used Wednesday’s market weakness to add $41.2 million worth of Broadcom ($AVGO), Cerebras Systems ($CBRS), and Rocket Lab ...
10x Genomics (TXG) Sees Strong Early Orders for New Atera Platform
On August 6, 10x Genomics (NASDAQ:TXG) reported second-quarter revenue of $151 million, boosted by a $1.6 million settlement payment from Takara.
10x Genomics, Inc. (NASDAQ:TXG) Q1 2026 Earnings Call Transcript
10x Genomics, Inc. (NASDAQ:TXG) Q1 2026 Earnings Call Transcript May 7, 202610x Genomics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.27.
10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript
10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript February 12, 202610x Genomics, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.19.
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending
We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. 10x Genomics, Inc. is one of the seven stocks on our list of most promising stocks.
7 Most Promising Gene Editing Stocks According to Analysts
In this article, we will be taking a look at the 7 Most Promising Gene Editing Stocks According to Analysts.
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch
10x Genomics, Inc. (NASDAQ:TXG) is one of the best digital health stocks to buy now.
10 Best Digital Health Stocks to Buy Now
Digital health’s 2025 shape is pretty clear: money is flowing again, AI is getting absorbed into real workflows, and policy is quietly forcing the pipes to talk to each other.
Hedge Fund Resource Center